Literature DB >> 15241827

Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group.

Edwin P Hui1, Sing F Leung, Joseph S K Au, Benny Zee, Stewart Tung, Daniel Chua, Wai M Sze, Chun K Law, To W Leung, Anthony T C Chan.   

Abstract

BACKGROUND: The current study was conducted to examine the pattern and the predictive factors of distant metastases (DM) in patients with nasopharyngeal carcinoma (NPC) after primary radiotherapy treatment.
METHODS: Data from all five regional cancer centers in Hong Kong were collected retrospectively and pooled for the current study, which was coordinated by the Hong Kong Nasopharyngeal Carcinoma Study Group. The sample was comprised of all 2915 patients with NPC without DM at the time of presentation who were treated with radiotherapy in 1 of the 5 cancer centers during the period between January 1996 and December 2000.
RESULTS: DM was found to be the leading cause of NPC failure, with a 5-year actuarial rate of 14.9% in this patient cohort. Despite the poor overall survival (OS) of these patients, those with lung metastasis alone represented a distinctive group associated with a significantly better OS. International Union Against Cancer (UICC) N classification, UICC T classification, advanced age, and male gender were found to be significant and independent determinants for DM.
CONCLUSIONS: Long-term survival is possible in patients with distant metastatic NPC confined to the lung. An aggressive approach to treatment for this group of patients should be considered. Copyright 2004 American Cancer Society.

Entities:  

Mesh:

Year:  2004        PMID: 15241827     DOI: 10.1002/cncr.20358

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  61 in total

1.  Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Authors:  Ting Jin; Xiao-Zhong Chen; Jian-Jiang Liu
Journal:  Oncol Lett       Date:  2015-06-10       Impact factor: 2.967

2.  M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.

Authors:  Lujun Shen; Jun Dong; Sheng Li; Yue Wang; Annan Dong; Wanhong Shu; Ming Wu; Changchuan Pan; Yunfei Xia; Peihong Wu
Journal:  Oncologist       Date:  2015-02-06

3.  Elevated apolipoprotein A-I levels are associated with favorable prognosis in metastatic nasopharyngeal carcinoma.

Authors:  Rou Jiang; Zhong-Han Yang; Dong-Hua Luo; Ling Guo; Rui Sun; Qiu-Yan Chen; Pei-Yu Huang; Fang Qiu; Xiong Zou; Ka-Jia Cao; Hai-Qiang Mai; Xiang Guo; Chao-Nan Qian; Ming-Huang Hong; Ming-Yuan Chen
Journal:  Med Oncol       Date:  2014-07-15       Impact factor: 3.064

4.  Changes in c-Kit expression levels during the course of radiation therapy for nasopharyngeal carcinoma.

Authors:  Feng Jiang; Wei Hu; Bicheng Zhang; Jing Xu; Yongjie Shui; Xiaofeng Zhou; Xiaoqiu Ren; Xiaozhong Chen; Li Shen; Qichun Wei
Journal:  Biomed Rep       Date:  2016-09-12

5.  Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma.

Authors:  Changchuan Pan; Yalan Tao; Ming Zhao; Wang Li; Zilin Huang; Jing Gao; Yanhen Wu; Jingrui Yu; Peihong Wu; Yunfei Xia; Jin Lu
Journal:  Exp Ther Med       Date:  2012-03-23       Impact factor: 2.447

6.  Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.

Authors:  Feng Pan; Zhihua Ruan; Jianjun Li; Xueli Pang; Yanling Zhang; Lan Zou; Houjie Liang
Journal:  Med Oncol       Date:  2015-10-15       Impact factor: 3.064

7.  IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy.

Authors:  X Fang; J-H Jeong; X Long; S-J Park; D Wang; M Shuai; R Wei; C Li; S Li; S Zhang; M B Duran; K-W Lo; S W Tsao; R Glaser; Z Luo; X Feng; Y Tian; J-L Luo
Journal:  Cell Death Differ       Date:  2016-04-08       Impact factor: 15.828

8.  Prognostic stratification of patients with metastatic nasopharyngeal carcinoma using a clinical and biochemical scoring system.

Authors:  Jeremy Chee; Kwok Seng Loh; Ivan Tham; Francis Ho; Lea Choung Wong; Chee Seng Tan; Boon Cher Goh; Chwee Ming Lim
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

9.  Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.

Authors:  Gui-Nan Lin; Jie-Wen Peng; Dong-Ying Liu; Jian-Jun Xiao; Yue-Qiong Chen; Xiao-Qin Chen
Journal:  Tumour Biol       Date:  2014-08-01

Review 10.  Nasopharyngeal carcinoma: an evolving paradigm.

Authors:  Kenneth C W Wong; Edwin P Hui; Kwok-Wai Lo; Wai Kei Jacky Lam; David Johnson; Lili Li; Qian Tao; Kwan Chee Allen Chan; Ka-Fai To; Ann D King; Brigette B Y Ma; Anthony T C Chan
Journal:  Nat Rev Clin Oncol       Date:  2021-06-30       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.